Author: Wei Liu#1,2, Yihua Fan#3,2, Renhong Wan4, Longmei Zhao3, Hang Lu3, Rongjun Liao3, Zhining Zhuang3, Xiaoping Guo3
1 Department of Rheumatism and Immunology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China firstname.lastname@example.org.
2 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
3 Department of Rheumatism and Immunology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
4 Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Conference/Journal: BMJ Open
Date published: 2021 Apr 21
Other: Volume ID: 11 , Issue ID: 4 , Pages: e046188 , Special Notes: doi: 10.1136/bmjopen-2020-046188. , Word Count: 207
Ankylosing spondylitis (AS) is a recurrent autoimmune disease that is associated with a high disability rate, which has a profound negative impact on daily life. It has been clinically reported that traditional qigong exercise has certain therapeutic advantages in treating AS; however, this postulation is not evidence-based. Therefore, this study will aim at systematically appraising the validity and safety of traditional qigong exercise in treating AS.
Methods and analysis:
We searched the English (PubMed, Embase, Web of Science and the Cochrane Library) and Chinese databases (China National Knowledge Infrastructure, Wan fang, VIP and Chinese biomedical database) for relevant information. Additionally, the Baidu Academic and Google Academic databases were manually searched to mine relevant information. Randomised controlled clinical trials of traditional qigong exercise in treating AS were searched from the establishment of the database to September 2020. Quality articles were extracted and independently evaluated by two researchers before inclusion in this study. Meta-analysis of the included articles was performed using the RevMan V.5.3 software.
Ethics and dissemination:
This study will not involve primary data collection, and formal ethics approval will, therefore, not be required. We aim to publish this systematic review in a peer-reviewed journal.
Trial registration number:
Keywords: complementary medicine; immunology; rheumatology.
PMID: 33883155 DOI: 10.1136/bmjopen-2020-046188